Xr Securities LLC Gilead Sciences, Inc. Call Options Transaction History

Xr Securities LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 02, 2023	SELL	$77.31 - $88.08 $146,889 - $167,352	-1,900 Reduced 35.19%	3,500 $290,000
Q4 2022 Jan 23, 2023	BUY	$62.32 - $89.47 $336,528 - $483,138	5,400 New	5,400 $0
Q3 2022 Oct 18, 2022	BUY	$59.54 - $68.01 $601,354 - $686,901	10,100 New	10,100 $9,000
Q4 2020 Jan 13, 2021	SELL	$56.65 - $64.55 $674,135 - $768,145	-11,900 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $558,900 - $702,720	-9,000 Reduced 43.06%	11,900 $6,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $1.51 Million - $1.76 Million	20,900 New	20,900 $72,000
Q1 2020 Apr 09, 2020	SELL	$62.63 - $80.22 $814,190 - $1.04 Million	-13,000 Closed	0 $0
Q4 2019 Jan 06, 2020	SELL	$61.62 - $67.78 $911,976 - $1 Million	-14,800 Reduced 53.24%	13,000 $4,000
Q4 2018 Jan 03, 2019	BUY	$60.54 - $79.0 $163,458 - $213,300	2,700 Added 10.76%	27,800 $22,000
Q3 2018 Oct 04, 2018	BUY	$71.28 - $78.92 $719,928 - $797,092	10,100 Added 67.33%	25,100 $34,000
Q2 2018 Jul 06, 2018	BUY	$64.88 - $75.68 $973,199 - $1.14 Million	15,000 New	15,000 $6,000

1,893

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Xr Securities LLC with notifications on news.